Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,6500.00,12/12/2015,GNRL,263311378
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,3150.00,07/29/2015,GNRL,294741638
189872,GNRL,"Medivation Inc.",CA,100000010858,3150.00,04/28/2015,GNRL,339304908
189872,GNRL,"Medivation Inc.",CA,100000010858,3150.00,08/12/2015,GNRL,339304938
189872,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,3000.00,11/11/2014,GNRL,227549530
189872,GNRL,"Amgen Inc.",CA,100000000203,3000.00,09/15/2015,GNRL,297314904
189872,GNRL,"Amgen Inc.",CA,100000000203,3000.00,09/01/2015,GNRL,297314912
189872,GNRL,"Amgen Inc.",CA,100000000203,3000.00,11/05/2015,GNRL,297314936
189872,GNRL,"Amgen Inc.",CA,100000000203,3000.00,04/21/2015,GNRL,297915462
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,2700.00,05/20/2015,GNRL,294839232
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,2700.00,05/13/2015,GNRL,294789684
189872,GNRL,"Medivation Inc.",CA,100000010858,2700.00,10/14/2015,GNRL,339304956
189872,GNRL,"Medivation Inc.",CA,100000010858,2700.00,03/19/2015,GNRL,339304874
189872,GNRL,"Medivation Inc.",CA,100000010858,2700.00,04/09/2015,GNRL,339304881
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,2500.00,11/13/2013,GNRL,104545054
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,2500.00,11/04/2013,GNRL,104544818
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,2500.00,02/28/2014,GNRL,198459984
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,2500.00,02/21/2014,GNRL,198460026
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,2500.00,05/22/2014,GNRL,198459936
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,2450.00,12/19/2014,GNRL,168613966
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,2450.00,08/19/2015,GNRL,332520553
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,2100.00,02/12/2014,GNRL,168511288
189872,GNRL,"Medivation Inc.",CA,100000010858,2100.00,07/17/2014,GNRL,221254504
189872,GNRL,"Medivation Inc.",CA,100000010858,2100.00,02/27/2014,GNRL,221253996
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,2100.00,01/21/2015,GNRL,295258340
189872,GNRL,"Genentech USA, Inc.",CA,100000000226,2100.00,07/09/2015,GNRL,318241064
189872,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,2000.00,09/25/2013,GNRL,21809143
189872,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,2000.00,11/21/2013,GNRL,21809138
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,2000.00,09/24/2014,GNRL,152649510
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,2000.00,09/25/2014,GNRL,152649500
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,2000.00,05/21/2014,GNRL,152649528
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,2000.00,05/21/2014,GNRL,152649520
189872,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,2000.00,03/13/2014,GNRL,173389148
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,2000.00,03/10/2015,GNRL,263311398
189872,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,1750.00,11/04/2014,GNRL,227549534
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,1721.13,03/10/2015,GNRL,263311396
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,1600.00,11/07/2013,GNRL,111780490
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,1600.00,09/26/2013,GNRL,111800120
189872,GNRL,"Celgene Corporation",NJ,100000000343,1500.00,05/06/2014,GNRL,189920168
189872,GNRL,"Celgene Corporation",NJ,100000000343,1500.00,07/22/2014,GNRL,189919324
189872,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,1500.00,05/06/2014,GNRL,227549526
189872,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,1500.00,01/15/2014,GNRL,227549522
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,1500.00,09/19/2015,GNRL,263311388
189872,GNRL,"Celgene Corporation",NJ,100000000343,1500.00,05/19/2015,GNRL,328261916
189872,GNRL,"Celgene Corporation",NJ,100000000343,1500.00,11/24/2015,GNRL,328502454
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,1437.66,11/06/2014,GNRL,168648724
189872,GNRL,"Celgene Corporation",NJ,100000000343,1250.00,09/11/2015,GNRL,328260564
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,1225.00,10/04/2014,GNRL,168531790
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,1225.00,10/04/2014,GNRL,168650377
189872,GNRL,"Medivation Inc.",CA,100000010858,1066.20,07/16/2015,GNRL,339304924
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,1020.60,09/17/2013,GNRL,104544808
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,1019.00,04/24/2014,GNRL,198459974
189872,GNRL,"Celgene Corporation",NJ,100000000343,810.24,05/08/2015,GNRL,328499478
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,804.20,06/26/2015,GNRL,295272550
189872,GNRL,"Amgen Inc.",CA,100000000203,800.00,09/18/2013,GNRL,8941497
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,800.00,08/28/2014,GNRL,198459924
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,772.20,10/04/2014,GNRL,168484108
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,769.80,10/01/2013,GNRL,104545050
189872,GNRL,"Amgen Inc.",CA,100000000203,747.20,08/15/2015,GNRL,297314916
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,700.00,12/19/2014,GNRL,168861156
189872,GNRL,"Medivation Inc.",CA,100000010858,664.60,07/16/2015,GNRL,339304926
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,631.20,06/26/2015,GNRL,294704016
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,615.42,03/18/2014,GNRL,198460022
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,600.00,12/16/2013,GNRL,104547498
189872,GNRL,"ARIAD Pharmaceuticals, Inc.",MA,100000010550,600.00,11/14/2015,GNRL,325872518
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,556.46,05/08/2015,GNRL,294752466
189872,GNRL,"Medivation Inc.",CA,100000010858,543.20,04/16/2015,GNRL,339304896
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,528.40,09/24/2014,GNRL,152649508
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,516.00,11/06/2014,GNRL,168381190
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,511.08,05/26/2014,GNRL,198459954
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,500.00,06/24/2015,GNRL,263311372
189872,GNRL,"Medivation Inc.",CA,100000010858,496.80,10/14/2015,GNRL,339304958
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,481.20,07/17/2015,GNRL,332513795
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,449.74,10/04/2014,GNRL,168927252
189872,GNRL,"Celgene Corporation",NJ,100000000343,440.20,08/28/2015,GNRL,328266872
189872,GNRL,"Celgene Corporation",NJ,100000000343,436.37,05/08/2015,GNRL,328263992
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,432.20,10/09/2013,GNRL,104545052
189872,GNRL,"Celgene Corporation",NJ,100000000343,432.20,05/08/2015,GNRL,328499476
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,423.00,12/11/2015,GNRL,263311392
189872,GNRL,"Amgen Inc.",CA,100000000203,406.75,11/20/2015,GNRL,297314932
189872,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,390.00,11/21/2013,GNRL,21809142
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,384.80,10/01/2013,GNRL,104545046
189872,GNRL,"Celgene Corporation",NJ,100000000343,372.60,11/12/2015,GNRL,328286064
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,350.00,11/12/2013,GNRL,111807036
189872,GNRL,"Celgene Corporation",NJ,100000000343,337.87,11/12/2015,GNRL,328285824
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,325.92,05/21/2014,GNRL,152649518
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,321.33,11/18/2014,GNRL,168837114
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,312.88,05/16/2014,GNRL,198459948
189872,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,307.59,11/21/2013,GNRL,21809140
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,301.28,09/26/2013,GNRL,111735586
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,300.75,09/24/2013,GNRL,104544810
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,288.09,01/22/2014,GNRL,168764124
189872,GNRL,"Medivation Inc.",CA,100000010858,280.00,04/16/2015,GNRL,339304898
189872,GNRL,"Celgene Corporation",NJ,100000000343,272.93,08/28/2015,GNRL,328266796
189872,GNRL,"Celgene Corporation",NJ,100000000343,272.23,11/12/2015,GNRL,328285690
189872,GNRL,"Medivation Inc.",CA,100000010858,267.68,07/16/2015,GNRL,339304930
189872,GNRL,"Celgene Corporation",NJ,100000000343,265.90,11/12/2015,GNRL,328286040
189872,GNRL,"Incyte Corporation",DE,100000000263,250.00,11/14/2015,GNRL,298503362
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,239.12,03/07/2014,GNRL,198459978
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,236.17,07/17/2015,GNRL,332513761
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,234.18,12/12/2015,GNRL,263311376
189872,GNRL,"Celgene Corporation",NJ,100000000343,229.13,06/09/2015,GNRL,328263988
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,223.10,05/13/2015,GNRL,294712716
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,220.19,04/29/2015,GNRL,294717846
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,215.83,11/07/2013,GNRL,111803680
189872,GNRL,"Amgen Inc.",CA,100000000203,213.90,04/21/2015,GNRL,297915460
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,213.57,12/12/2015,GNRL,263311374
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,210.46,09/19/2015,GNRL,263311386
189872,GNRL,"Amgen Inc.",CA,100000000203,201.41,08/15/2015,GNRL,297314920
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,200.48,11/07/2013,GNRL,111756650
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,198.88,09/26/2013,GNRL,111737592
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,196.85,03/18/2014,GNRL,198460009
189872,GNRL,"Medivation Inc.",CA,100000010858,195.38,02/27/2014,GNRL,221254002
189872,GNRL,"Celgene Corporation",NJ,100000000343,189.61,08/28/2015,GNRL,328263824
189872,GNRL,"Medivation Inc.",CA,100000010858,189.28,04/16/2015,GNRL,339304902
189872,GNRL,"Medivation Inc.",CA,100000010858,183.12,02/27/2014,GNRL,221255176
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,179.68,09/19/2015,GNRL,263311384
189872,GNRL,"Genentech USA, Inc.",CA,100000000226,174.08,07/09/2015,GNRL,317992022
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,172.26,03/04/2014,GNRL,198459989
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,170.23,09/25/2014,GNRL,152649498
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,170.23,09/24/2014,GNRL,152649506
189872,GNRL,"Celgene Corporation",NJ,100000000343,168.29,08/28/2015,GNRL,328258534
189872,GNRL,"Medivation Inc.",CA,100000010858,166.88,07/17/2014,GNRL,221255258
189872,GNRL,"Medivation Inc.",CA,100000010858,166.88,03/18/2015,GNRL,339304868
189872,GNRL,"Celgene Corporation",NJ,100000000343,166.25,05/08/2015,GNRL,328264546
189872,GNRL,"Medivation Inc.",CA,100000010858,153.23,07/17/2014,GNRL,221254508
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,152.32,09/26/2013,GNRL,104544812
189872,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,146.42,11/21/2013,GNRL,21809141
189872,GNRL,"Amgen Inc.",CA,100000000203,145.61,08/15/2015,GNRL,297314928
189872,GNRL,"Amgen Inc.",CA,100000000203,144.08,08/15/2015,GNRL,297314926
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,143.08,06/05/2014,GNRL,198459932
189872,GNRL,"Celgene Corporation",NJ,100000000343,139.70,07/15/2014,GNRL,189916428
189872,GNRL,"Amgen Inc.",CA,100000000203,139.19,04/09/2015,GNRL,297915458
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,136.52,09/26/2013,GNRL,104544814
189872,GNRL,"Medivation Inc.",CA,100000010858,135.21,09/28/2015,GNRL,339304948
189872,GNRL,"Seattle Genetics, Inc.",WA,100000000279,135.16,08/23/2015,GNRL,341825358
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,134.84,05/21/2014,GNRL,152649516
189872,GNRL,"Celgene Corporation",NJ,100000000343,126.52,12/10/2015,GNRL,328494230
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,125.00,10/04/2014,GNRL,168707323
189872,GNRL,"Amgen Inc.",CA,100000000203,125.00,10/14/2015,GNRL,297314908
189872,GNRL,"ARIAD Pharmaceuticals, Inc.",MA,100000010550,124.55,11/14/2015,GNRL,325872582
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,119.42,09/19/2015,GNRL,263311390
189872,GNRL,"Amgen Inc.",CA,100000000203,117.70,09/04/2014,GNRL,138087970
189872,GNRL,"Millennium Pharmaceuticals, Inc.",MA,100000000080,115.09,05/04/2015,GNRL,335417042
189872,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,113.68,10/03/2013,GNRL,102468644
189872,GNRL,"Lilly USA, LLC",IN,100000000066,113.00,05/18/2015,GNRL,267746910
189872,GNRL,"ASD Specialty Healthcare, Inc.",TX,100000010920,112.84,10/30/2014,GNRL,195521440
189872,GNRL,"Medivation Inc.",CA,100000010858,109.79,04/09/2015,GNRL,339304884
189872,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,105.85,11/10/2015,GNRL,290464968
189872,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,103.59,12/04/2013,GNRL,102468250
189872,GNRL,"Medivation Inc.",CA,100000010858,102.99,04/16/2015,GNRL,339304904
189872,GNRL,"Genentech USA, Inc.",CA,100000000226,100.38,11/02/2015,GNRL,318132468
189872,GNRL,"Medivation Inc.",CA,100000010858,98.58,07/17/2014,GNRL,221254506
189872,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,97.99,10/29/2014,GNRL,227549528
189872,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,97.62,04/23/2014,GNRL,227549524
189872,GNRL,"Celgene Corporation",NJ,100000000343,97.46,04/15/2015,GNRL,328257518
189872,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,97.28,11/09/2015,GNRL,338123776
189872,GNRL,"Amgen Inc.",CA,100000000203,97.12,04/09/2015,GNRL,297915456
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,96.29,11/06/2014,GNRL,168916216
189872,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,96.06,06/16/2015,GNRL,290464970
189872,GNRL,"Celgene Corporation",NJ,100000000343,95.44,10/09/2013,GNRL,101789754
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,95.22,09/26/2013,GNRL,111763796
189872,GNRL,"Amgen Inc.",CA,100000000203,94.85,04/01/2015,GNRL,297915450
189872,GNRL,"Celgene Corporation",NJ,100000000343,94.27,08/18/2014,GNRL,189888904
189872,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,94.11,08/27/2013,GNRL,14240859
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,93.48,07/29/2015,GNRL,294815062
189872,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,91.81,03/05/2014,GNRL,196311024
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,91.44,09/24/2014,GNRL,152649512
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,91.28,11/18/2014,GNRL,168537124
189872,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,90.48,03/13/2014,GNRL,173389142
189872,GNRL,"Seattle Genetics, Inc.",WA,100000000279,89.16,08/20/2013,GNRL,25422790
189872,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,88.62,02/09/2015,GNRL,274993734
189872,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,88.61,09/09/2015,GNRL,319050146
189872,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,88.45,09/09/2015,GNRL,319179767
189872,GNRL,"Celgene Corporation",NJ,100000000343,88.36,06/18/2015,GNRL,328258026
189872,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,87.86,09/25/2013,GNRL,21809144
189872,GNRL,"Cardinal Health 108, LLC",OH,100000010445,87.47,09/23/2014,GNRL,145691442
189872,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,86.94,06/24/2015,GNRL,274993742
189872,GNRL,"Pharmacyclics LLC, An AbbVie Company",CA,100000136439,86.64,10/22/2015,GNRL,326067400
189872,GNRL,"Cardinal Health 108, LLC",OH,100000010445,86.60,04/15/2014,GNRL,145688324
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,86.28,03/01/2014,GNRL,198459995
189872,GNRL,"Cardinal Health 108, LLC",OH,100000010445,86.20,09/03/2014,GNRL,145691474
189872,GNRL,"Amgen Inc.",CA,100000000203,86.03,05/19/2015,GNRL,297915464
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,85.88,12/12/2015,GNRL,263311380
189872,GNRL,"Celgene Corporation",NJ,100000000343,84.85,12/10/2014,GNRL,189940456
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,84.81,12/12/2015,GNRL,263311432
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,83.47,04/22/2014,GNRL,168442458
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,83.00,03/10/2015,GNRL,263311400
189872,GNRL,"Celgene Corporation",NJ,100000000343,82.89,06/23/2015,GNRL,328277426
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,82.88,05/21/2014,GNRL,152649526
189872,GNRL,"Amgen Inc.",CA,100000000203,82.00,10/14/2015,GNRL,297314946
189872,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,80.89,11/10/2014,GNRL,227549532
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,76.61,09/20/2013,GNRL,104551934
189872,GNRL,"Cardinal Health 108, LLC",OH,100000010445,75.34,06/25/2014,GNRL,145688384
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,74.55,09/24/2014,GNRL,152649514
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,74.55,09/25/2014,GNRL,152649504
189872,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,73.00,05/06/2015,GNRL,274993736
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,71.68,07/17/2015,GNRL,332513597
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,71.64,05/21/2014,GNRL,152649522
189872,GNRL,"Cardinal Health 108, LLC",OH,100000010445,71.07,08/21/2015,GNRL,292915660
189872,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,69.89,11/17/2015,GNRL,331048997
189872,GNRL,"Cardinal Health 108, LLC",OH,100000010445,65.61,01/13/2015,GNRL,292915208
189872,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,65.31,12/19/2013,GNRL,102469264
189872,GNRL,"Cardinal Health 108, LLC",OH,100000010445,65.21,10/21/2014,GNRL,145691628
189872,GNRL,"Cardinal Health 108, LLC",OH,100000010445,64.75,11/04/2014,GNRL,145691784
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,60.00,10/04/2014,GNRL,168643897
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,59.00,05/21/2014,GNRL,152649524
189872,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,56.54,11/21/2013,GNRL,21809139
189872,GNRL,"Medivation Inc.",CA,100000010858,56.00,02/27/2014,GNRL,221253998
189872,GNRL,"Cardinal Health 108, LLC",OH,100000010445,54.75,09/16/2015,GNRL,292915728
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,54.39,04/29/2015,GNRL,295213042
189872,GNRL,"Celgene Corporation",NJ,100000000343,53.75,07/15/2014,GNRL,189918882
189872,GNRL,"Gilead Sciences Inc",CA,100000000108,52.14,12/01/2014,GNRL,168306492
189872,GNRL,"Medivation Inc.",CA,100000010858,52.00,04/09/2015,GNRL,339304886
189872,GNRL,"Janssen Products, LP",PA,100000000325,51.99,08/19/2013,GNRL,17399988
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,51.99,09/24/2013,GNRL,111799048
189872,GNRL,"ASD Specialty Healthcare, Inc.",TX,100000010920,51.30,08/26/2013,GNRL,103132492
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,51.00,07/18/2015,GNRL,332513697
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,50.96,11/06/2013,GNRL,24099925
189872,GNRL,"Cardinal Health 108, LLC",OH,100000010445,50.01,09/14/2015,GNRL,292915702
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,50.00,10/04/2014,GNRL,168845892
189872,GNRL,"Medivation Inc.",CA,100000010858,48.00,10/14/2015,GNRL,339304962
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,47.51,01/22/2014,GNRL,168526046
189872,GNRL,"Medivation Inc.",CA,100000010858,47.24,08/12/2015,GNRL,339304944
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,43.63,09/25/2014,GNRL,152649502
189872,GNRL,"Celgene Corporation",NJ,100000000343,43.25,12/06/2014,GNRL,189873518
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,42.51,07/18/2015,GNRL,332513661
189872,GNRL,"Celgene Corporation",NJ,100000000343,40.86,05/12/2015,GNRL,328505276
189872,GNRL,"Medivation Inc.",CA,100000010858,38.23,04/28/2015,GNRL,339304910
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,37.50,11/07/2013,GNRL,111784810
189872,GNRL,"Medivation Inc.",CA,100000010858,37.30,07/16/2015,GNRL,339304934
189872,GNRL,"Cardinal Health 108, LLC",OH,100000010445,36.76,06/26/2014,GNRL,145688370
189872,GNRL,"Medivation Inc.",CA,100000010858,36.19,08/12/2015,GNRL,339304942
189872,GNRL,"Medivation Inc.",CA,100000010858,35.65,03/19/2015,GNRL,339304878
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,35.00,10/04/2014,GNRL,168421754
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,35.00,10/04/2014,GNRL,168541128
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,35.00,03/10/2015,GNRL,263311402
189872,GNRL,"Celgene Corporation",NJ,100000000343,31.80,08/27/2015,GNRL,328426276
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,25.89,07/18/2015,GNRL,332513629
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,25.89,07/18/2015,GNRL,332513729
189872,GNRL,"Medivation Inc.",CA,100000010858,25.00,04/28/2015,GNRL,339304914
189872,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,23.97,08/13/2013,GNRL,21809145
189872,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,23.37,09/02/2015,GNRL,260109726
189872,GNRL,"Celgene Corporation",NJ,100000000343,23.00,06/09/2015,GNRL,328257462
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,22.48,09/11/2013,GNRL,104550572
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,21.88,05/15/2014,GNRL,198459960
189872,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,20.89,12/30/2015,GNRL,290464972
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,20.64,03/11/2014,GNRL,187798710
189872,GNRL,"Purdue Pharma L.P.",CT,100000005432,19.77,02/03/2015,GNRL,251029094
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.74,06/17/2014,GNRL,187927926
189872,GNRL,"Celgene Corporation",NJ,100000000343,19.47,11/04/2014,GNRL,189848150
189872,GNRL,"Genentech USA, Inc.",CA,100000000226,19.43,11/16/2015,GNRL,317967650
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,19.07,02/25/2014,GNRL,168915210
189872,GNRL,"Genentech USA, Inc.",CA,100000000226,19.00,07/16/2014,GNRL,208154374
189872,GNRL,"Genentech USA, Inc.",CA,100000000226,19.00,04/23/2014,GNRL,208382530
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,18.28,07/28/2015,GNRL,263311410
189872,GNRL,"Genentech USA, Inc.",CA,100000000226,18.27,04/22/2015,GNRL,318196066
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,17.92,02/24/2015,GNRL,263311430
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,17.86,08/06/2014,GNRL,152649538
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,17.80,07/08/2014,GNRL,152649494
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,17.69,05/05/2015,GNRL,331671571
189872,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,17.33,10/28/2015,GNRL,319456183
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,17.28,06/26/2015,GNRL,295302264
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,17.27,11/05/2013,GNRL,24099929
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,17.15,09/18/2013,GNRL,24099924
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,17.03,05/08/2015,GNRL,295116439
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,16.65,09/01/2015,GNRL,331907475
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,16.60,04/01/2015,GNRL,331588233
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,16.57,11/18/2014,GNRL,152649550
189872,GNRL,"Eisai Inc.",NJ,100000000136,16.55,01/08/2014,GNRL,184747288
189872,GNRL,"LILLY USA, LLC",IN,100000000066,16.47,08/19/2014,GNRL,137827664
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,16.47,03/31/2015,GNRL,263311420
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,16.40,08/12/2014,GNRL,152649544
189872,GNRL,"Bayer HealthCare Pharmaceuticals Inc.",NJ,100000005467,16.40,10/16/2014,GNRL,219018924
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,16.36,09/10/2015,GNRL,263311406
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,16.23,10/07/2014,GNRL,152649496
189872,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,15.95,10/09/2013,GNRL,14243582
189872,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,15.82,01/28/2014,GNRL,173389152
189872,GNRL,"Medivation Inc.",CA,100000010858,15.47,02/27/2014,GNRL,221254000
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,15.27,06/23/2014,GNRL,152649534
189872,GNRL,"Medivation Inc.",CA,100000010858,15.01,09/28/2015,GNRL,339304952
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.00,10/01/2013,GNRL,104545048
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.00,09/15/2013,GNRL,104544806
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.00,05/20/2014,GNRL,198459944
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.00,04/24/2014,GNRL,198459968
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.00,02/28/2014,GNRL,198460015
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.00,02/11/2014,GNRL,198460038
189872,GNRL,"Medivation Inc.",CA,100000010858,14.99,10/08/2014,GNRL,221247750
189872,GNRL,"Genentech USA, Inc.",CA,100000000226,14.94,08/27/2013,GNRL,29800184
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,14.84,08/28/2013,GNRL,24099927
189872,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.83,01/20/2015,GNRL,319333723
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,14.81,01/16/2015,GNRL,263311404
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,14.43,04/29/2015,GNRL,263311418
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,14.42,06/04/2014,GNRL,152649480
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,14.34,05/28/2014,GNRL,152649492
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,14.33,08/06/2015,GNRL,295257434
189872,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.26,06/11/2014,GNRL,196311020
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,14.24,01/29/2014,GNRL,152649482
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,14.24,09/30/2014,GNRL,152649488
189872,GNRL,"Janssen Biotech, Inc.",PA,100000000329,14.13,11/30/2015,GNRL,269966224
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,14.10,02/24/2015,GNRL,263311428
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,14.08,04/07/2015,GNRL,263311422
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,14.06,08/18/2015,GNRL,263311408
189872,GNRL,"Amgen Inc.",CA,100000000203,14.03,10/13/2015,GNRL,297314942
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,14.00,10/04/2013,GNRL,104544816
189872,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,13.98,08/19/2015,GNRL,333460502
189872,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,13.89,03/04/2014,GNRL,202773364
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,13.87,11/10/2015,GNRL,263311382
189872,GNRL,"Eisai Inc.",NJ,100000000136,13.86,10/29/2013,GNRL,152509332
189872,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.71,01/07/2014,GNRL,196311022
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,13.69,07/29/2015,GNRL,295126620
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,13.68,05/20/2015,GNRL,295290958
189872,GNRL,"Amgen Inc.",CA,100000000203,13.65,08/04/2015,GNRL,297915454
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,13.62,09/04/2013,GNRL,111759590
189872,GNRL,"Amgen Inc.",CA,100000000203,13.59,06/18/2014,GNRL,138087964
189872,GNRL,"LILLY USA, LLC",IN,100000000066,13.52,12/03/2013,GNRL,4720531
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,13.47,12/11/2013,GNRL,24099928
189872,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.47,12/22/2015,GNRL,274993730
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,13.40,03/05/2014,GNRL,152649552
189872,GNRL,"Eisai Inc.",NJ,100000000136,13.39,03/12/2014,GNRL,184747290
189872,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,13.30,12/04/2013,GNRL,102468150
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,13.23,02/18/2015,GNRL,331529727
189872,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.22,01/13/2015,GNRL,274993724
189872,GNRL,"Celgene Corporation",NJ,100000000343,13.22,09/08/2015,GNRL,328428086
189872,GNRL,"Luitpold Pharmaceuticals Inc",NY,100000010540,13.04,10/22/2013,GNRL,29499411
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,13.04,10/06/2015,GNRL,263311362
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,12.96,10/07/2013,GNRL,24099934
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,12.91,09/24/2013,GNRL,14056268
189872,GNRL,"Celgene Corporation",NJ,100000000343,12.88,04/01/2014,GNRL,189941122
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,12.87,05/20/2015,GNRL,331673517
189872,GNRL,"Amgen Inc.",CA,100000000203,12.67,11/26/2013,GNRL,8941495
189872,GNRL,"Pfizer Inc.",NY,100000000286,12.60,01/06/2015,GNRL,322921888
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,12.45,09/22/2015,GNRL,263311358
189872,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,12.42,09/04/2015,GNRL,293540646
189872,GNRL,"Medivation Inc.",CA,100000010858,12.39,07/15/2015,GNRL,339304920
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,12.32,11/11/2014,GNRL,168887286
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,12.22,11/06/2014,GNRL,168562445
189872,GNRL,"Amgen Inc.",CA,100000000203,12.19,04/22/2014,GNRL,138087966
189872,GNRL,"Genentech USA, Inc.",CA,100000000226,12.18,11/06/2013,GNRL,29800048
189872,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.12,01/14/2014,GNRL,188504972
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,12.10,08/06/2013,GNRL,24099930
189872,GNRL,"Amgen Inc.",CA,100000000203,12.10,03/25/2014,GNRL,138087962
189872,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,12.09,10/15/2013,GNRL,171840038
189872,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.99,05/06/2015,GNRL,274993738
189872,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.87,12/02/2015,GNRL,274993726
189872,GNRL,"Ipsen Biopharmaceuticals, Inc",NJ,100000000123,11.86,09/16/2015,GNRL,341511342
189872,GNRL,"Genentech USA, Inc.",CA,100000000226,11.84,11/12/2013,GNRL,29800186
189872,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.81,06/16/2015,GNRL,274993744
189872,GNRL,"Pfizer Inc.",NY,100000000286,11.76,09/21/2015,GNRL,323283835
189872,GNRL,"Pfizer Inc.",NY,100000000286,11.74,03/03/2015,GNRL,322615958
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,11.72,09/14/2015,GNRL,263311360
189872,GNRL,"Amgen Inc.",CA,100000000203,11.72,05/26/2015,GNRL,297314900
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.71,03/25/2015,GNRL,331573191
189872,GNRL,"Genentech USA, Inc.",CA,100000000226,11.66,08/14/2013,GNRL,29800187
189872,GNRL,"Janssen Diagnostics, LLC",NJ,100000005596,11.58,07/23/2014,GNRL,155722566
189872,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.50,11/13/2013,GNRL,14295925
189872,GNRL,"Pfizer Inc.",NY,100000000286,11.50,06/24/2015,GNRL,322764288
189872,GNRL,"Pfizer Inc.",NY,100000000286,11.46,02/10/2015,GNRL,323713172
189872,GNRL,"Eisai Inc.",NJ,100000000136,11.41,11/24/2014,GNRL,184747292
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,11.29,06/17/2015,GNRL,263311394
189872,GNRL,"Genentech USA, Inc.",CA,100000000226,11.18,08/20/2013,GNRL,29800185
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.14,12/03/2014,GNRL,188170382
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,11.03,06/17/2015,GNRL,263311412
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.99,02/26/2014,GNRL,152649530
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.88,06/25/2014,GNRL,152649486
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.70,12/23/2015,GNRL,332257527
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.66,10/07/2013,GNRL,24099933
189872,GNRL,"Bayer HealthCare Pharmaceuticals Inc.",NJ,100000005467,10.66,09/10/2013,GNRL,31047942
189872,GNRL,"Bayer HealthCare Pharmaceuticals Inc.",NJ,100000005467,10.64,09/10/2013,GNRL,31070227
189872,GNRL,"Amgen Inc.",CA,100000000203,10.63,09/03/2014,GNRL,138087968
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.62,11/05/2014,GNRL,152649532
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,10.52,10/07/2015,GNRL,263311364
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.45,09/16/2014,GNRL,198459908
189872,GNRL,"Amgen Inc.",CA,100000000203,10.38,06/03/2015,GNRL,297314938
189872,GNRL,"Medivation Inc.",CA,100000010858,10.34,04/15/2015,GNRL,339304890
189872,GNRL,"EISAI INC.",NJ,100000000136,10.33,04/21/2015,GNRL,337968728
189872,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.28,10/22/2014,GNRL,202766020
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,9.94,10/22/2014,GNRL,152649540
189872,GNRL,"Seattle Genetics, Inc.",WA,100000000279,9.80,08/07/2013,GNRL,25422789
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,9.78,09/15/2015,GNRL,331954505
189872,GNRL,"Seattle Genetics, Inc.",WA,100000000279,9.76,11/19/2013,GNRL,25422791
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,9.73,09/09/2014,GNRL,152649546
189872,GNRL,"Celgene Corporation",NJ,100000000343,9.61,02/19/2015,GNRL,328300010
189872,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,9.42,02/22/2014,GNRL,198460032
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,9.11,10/28/2014,GNRL,152649548
189872,GNRL,"Celgene Corporation",NJ,100000000343,8.89,02/17/2015,GNRL,328328638
189872,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,8.80,10/03/2013,GNRL,102468254
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,8.74,03/11/2015,GNRL,263311424
189872,GNRL,"Seattle Genetics, Inc.",WA,100000000279,8.73,11/11/2015,GNRL,341825362
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,8.56,11/18/2015,GNRL,263311368
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,8.53,05/21/2014,GNRL,152649542
189872,GNRL,"Medivation Inc.",CA,100000010858,8.53,07/01/2014,GNRL,221243934
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,8.20,06/10/2015,GNRL,263311416
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,8.13,10/23/2013,GNRL,24099923
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,8.06,10/29/2015,GNRL,263311366
189872,GNRL,"Celgene Corporation",NJ,100000000343,7.95,10/29/2014,GNRL,189852970
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,7.68,02/04/2014,GNRL,152649490
189872,GNRL,"Seattle Genetics, Inc.",WA,100000000279,7.65,04/08/2015,GNRL,341825350
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,7.64,12/15/2015,GNRL,263311370
189872,GNRL,"Seattle Genetics, Inc.",WA,100000000279,7.62,07/07/2015,GNRL,341825354
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,7.50,04/30/2014,GNRL,152649476
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,7.36,05/19/2015,GNRL,263311414
189872,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,7.33,11/25/2015,GNRL,338125390
189872,GNRL,"Seattle Genetics, Inc.",WA,100000000279,7.33,02/19/2015,GNRL,341825346
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,7.18,11/27/2013,GNRL,24099932
189872,GNRL,"Luitpold Pharmaceuticals Inc",NY,100000010540,7.08,05/20/2014,GNRL,172031690
189872,GNRL,"Amgen Inc.",CA,100000000203,6.80,11/05/2013,GNRL,8941496
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,6.74,03/26/2014,GNRL,152649484
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,6.56,08/26/2015,GNRL,294906470
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,6.49,10/23/2013,GNRL,24099926
189872,GNRL,"Celgene Corporation",NJ,100000000343,6.44,07/21/2015,GNRL,328283520
189872,GNRL,"Genentech USA, Inc.",CA,100000000226,5.94,11/04/2015,GNRL,317831414
189872,GNRL,"Lilly USA, LLC",IN,100000000066,5.88,03/04/2015,GNRL,267746908
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,5.80,07/17/2015,GNRL,332513563
189872,GNRL,"Medivation Inc.",CA,100000010858,5.44,10/08/2014,GNRL,221235150
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,5.43,12/02/2014,GNRL,168852214
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,5.36,09/10/2013,GNRL,24099931
189872,GNRL,"Celgene Corporation",NJ,100000000343,4.89,01/12/2015,GNRL,328306602
189872,GNRL,"Medivation Inc.",CA,100000010858,4.87,07/01/2014,GNRL,221243936
189872,GNRL,"Medivation Inc.",CA,100000010858,3.52,07/01/2014,GNRL,221235018
189872,GNRL,"Lilly USA, LLC",IN,100000000066,3.19,03/04/2015,GNRL,267746904
189872,GNRL,"Medivation Inc.",CA,100000010858,3.04,07/01/2014,GNRL,221235014
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,2.68,05/20/2015,GNRL,331673501
189872,GNRL,"Amgen Inc.",CA,100000000203,1.93,02/13/2014,GNRL,138087960
189872,GNRL,"Luitpold Pharmaceuticals Inc",NY,100000010540,1.88,05/20/2014,GNRL,172031684
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,1.87,08/06/2015,GNRL,294761616
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1.82,05/20/2015,GNRL,331673509
189872,GNRL,"LILLY USA, LLC",IN,100000000066,1.81,12/03/2013,GNRL,4723789
189872,GNRL,"Lilly USA, LLC",IN,100000000066,1.77,03/04/2015,GNRL,267746906
189872,GNRL,"Luitpold Pharmaceuticals Inc",NY,100000010540,1.39,10/22/2013,GNRL,29499420
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,1.07,03/10/2015,GNRL,295122118
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,1.04,08/06/2014,GNRL,152649536
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,0.99,04/30/2014,GNRL,152649478
189872,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,0.96,10/23/2013,GNRL,24099922
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,0.95,09/15/2015,GNRL,331954521
189872,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.83,05/06/2015,GNRL,274993740
189872,GNRL,"Genentech USA, Inc.",CA,100000000226,0.83,11/04/2015,GNRL,318203584
189872,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,0.82,03/11/2015,GNRL,263311426
189872,GNRL,"Medivation Inc.",CA,100000010858,0.81,07/15/2015,GNRL,339304916
189872,GNRL,"Luitpold Pharmaceuticals Inc",NY,100000010540,0.75,10/22/2013,GNRL,29499410
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,0.73,03/25/2015,GNRL,331573189
189872,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.66,06/16/2015,GNRL,274993746
189872,GNRL,"Medivation Inc.",CA,100000010858,0.63,10/20/2015,GNRL,339304964
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,0.61,05/05/2015,GNRL,331671559
189872,GNRL,"Medivation Inc.",CA,100000010858,0.61,04/15/2015,GNRL,339304892
189872,GNRL,"Medivation Inc.",CA,100000010858,0.58,10/08/2014,GNRL,221247756
189872,GNRL,"Astellas Pharma US Inc",IL,100000000137,0.58,08/26/2015,GNRL,294906502
189872,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,0.54,09/01/2015,GNRL,331907497
189872,GNRL,"Amgen Inc.",CA,100000000203,0.53,08/04/2015,GNRL,297915452
189872,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.47,12/22/2015,GNRL,274993728
189872,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.37,01/13/2015,GNRL,274993732
